伊科德克斯对患有充血性心力衰竭的腹腔透析患者的影响:可变时间暴露设计和向试验仿真方法
Li-Yi Ma1, Yi-Ran Tu1,2, Ming-Jen Chan1,2
1Department of Nephrology, Kidney Research Center, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan.
概括
在腹腔透析 (PD) 患有充血性心力衰竭 (CHF) 的患者中使用icodextrin显著降低了死亡率和主要不良心血管事件 (MACE). 这表明,iCodextrin可能会改善这个高风险组的结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 临床研究 临床研究
背景情况:
- 伊科德克斯是一种替代性腹膜透析 (PD) 溶液.
- 有限证据表明,在患有充血性心力衰竭 (CHF) 的PD患者中使用伊科德克斯.
研究的目的:
- 检查ICodextrin使用与CHFPD患者的PD临床结果之间的关联.
- 在这个特定的患者群体中评估生存率和心血管事件率.
主要方法:
- 从2005年到2022年,对1,800名患有心血管衰竭的PD患者进行了回顾性队列研究.
- 与非使用者相比,使用伊科德克斯 (≥50%的PD持续时间) 的人的比较.
- 使用多变量Cox比例危险模型和灵敏度分析进行分析.
主要成果:
- 伊科德克斯的使用与所有原因死亡率 (HR:0.16),心血管死亡率 (HR:0.20),突然死亡 (HR:0.15) 和MACE (HR:0.68) 的风险显著降低.
- 与封装腹膜硬化症和过渡到血液透析的风险降低有关.
- 在icodextrin使用者中观察到较低的移植率.
结论:
- 伊科德克斯的使用独立地与患有心血管衰竭的PD患者的生存率和心血管结果的改善有关.
- 调查结果支持在患PD高风险人群中优先使用伊科德克斯.
- 需要进一步的前性研究来证实这些益处.
更多相关视频
相关概念视频
Peritoneal Dialysis I: Introduction and Procedure
2.1K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
2.1K
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
476
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
476
Heart Failure Drugs: Diuretics
764
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
764
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
217
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
217
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
215
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
215
Dialysis
1.6K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.6K


